Article Sidebar

Submitted
September 1, 2025
Accepted
December 10, 2025
Published
December 31, 2025
Download
PDF
Statistic
Read Counter : 220

Main Article Content

Abstract

Background: Infantile Systemic Hyalinosis (ISH) is a very rare and severe autosomal recessive disease, in which amorphous hyalineaceous material is deposited extensively in different tissues and presents a multisystemic clinical manifestation. This debilitating disease, based on a biallelic mutation of the ANTXR2 gene, is typically characterized by a course of infancy and progressive joint contractures, painful papules and macules on the skin, gingival hypertrophy, gastrointestinal dysfunction, and failure to thrive. Despite such melodies' effects on people who are affected and it is a poorly-known disease that has few known therapeutic options. This systematic literature review seeks to summarize the knowledge on ISH, including acrylic-based knowledge, genetic foundation, molecular pathophysiology, etc., various clinical expressions, diagnostic and treatment implementations. The study will be going to explore the specific characteristics that separate ISH and its allele Juvenile Hyaline Fibromatosis (JHF), which is a counterpart and speaks of the problems in diagnosis and early intervention, which is vital, through pooling together information based on the case reports and literature reviews in the short term.ISH is a strong reminder of how complicated rare things can be genetic disorders. Increased sensitization among health professionals, as well as Speedy and precise diagnosis, plays the utmost role in maximizing supportive care, enhancing the lives of the affected infants.

Keywords

Infantile Systemic Hyalinosis ISH ANTXR2 Hyaline Fibromatosis Syndrome Genetic Disorder

Article Details

License

Copyright (c) 2025 Maha Mashrq AlBayati, Wurood Kadhim Abed, Thualfakar Hayder Hasan (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Maha Mashrq AlBayati, Wurood Kadhim Abed and Thualfakar Hayder Hasan (2025) “Infantile Systemic Hyalinosis (ISH): A Comprehensive Review of Its Genetic Basis, Clinical Spectrum, and Therapeutic Challenges”, Journal of Biomedicine and Biochemistry, 4(4), pp. 89–96. doi:10.57238/jbb.2025.7432.1158.
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

How to Cite

Maha Mashrq AlBayati, Wurood Kadhim Abed and Thualfakar Hayder Hasan (2025) “Infantile Systemic Hyalinosis (ISH): A Comprehensive Review of Its Genetic Basis, Clinical Spectrum, and Therapeutic Challenges”, Journal of Biomedicine and Biochemistry, 4(4), pp. 89–96. doi:10.57238/jbb.2025.7432.1158.
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Ghotbabadi SH, Shiari R, Yousufzai S, Sharifi S. Genetic insights into hyaline fibromatosis syndrome: A case report of an ANTXR2 mutation featuring a rare variant c.697+1G>A. Clin Case Rep. 2025;13(4):e70312. https://doi.org/10.1002/ccr3.70312.
  2. Jaiswal S, Madke B, Chandak M, Jangid S. Infantile systemic hyalinosis. Indian J Paediatr Dermatol. 2024;25(2):128-131. https://doi.org/10.4103/ijpd.ijpd_15_24.
  3. Sangwan P, Shreya K, Rout AN, Jaladi HC. Infantile systemic hyalinosis: A case report with a brief review. Indian Dermatol Online J. 2024;15(5):856-858. https://doi.org/10.4103/idoj.idoj_631_23.
  4. Seth NH, Sharath HV, Raghuveer R, Sharath HV. Effect of paediatric rehabilitation in infantile systemic hyalinosis: A case report. Cureus. 2024;16(6):e61866. https://doi.org/10.7759/cureus.61866.
  5. Archana CA, Sekar YS, Suresh KP, Subramaniam S, Sagar N, Rani S, et al. Investigating the influence of ANTXR2 gene mutations on protective antigen binding for heightened anthrax resistance. Genes. 2024;15(4):426. https://doi.org/10.3390/genes15040426.
  6. Augustine M, Ballal S, Tirumalae R, Sequeira VE. Lumps and bumps in a young child: Hyaline fibromatosis syndrome. Karnataka Paediatr J. 2024;39(3):98-101. https://doi.org/10.25259/KPJ_12_2024.
  7. Mohammed, S. E., Mohammed, M. M., Saeed, M., Al Zahrani, D., & Alasmari, B. G. (2023). Infantile Systemic Hyalinosis: A Case Report and Literature Review. Cureus, 15(10), e46519. https://doi.org/10.7759/cureus.46519.
  8. Al Kaissi, A., Hilmi, M., Betadolova, Z., Bouchoucha, S., Trofimova, S., Shboul, M., Rustamov, G., Dwera, W., Sigl, K., Kenis, V., & Kircher, S. G. (2021). Infantile systemic hyalinosis: Variable grades of severity. African journal of paediatric surgery : AJPS, 18(4), 224–230. https://doi.org/10.4103/ajps.AJPS_162_20.
  9. Vagha JD, Wazurkar A, Madke B, Lohiya S, Wandile S, Vagha K, et al. Beyond skin deep: A case report of infantile systemic hyalinosis in a six-month-old infant. Cureus. 2024;16(5):e59510. https://doi.org/10.7759/cureus.59510
  10. Gowda VK, Srinivas SM, Gupta P, Srinivasan VM, Shivappa SK, Vishwanathan GB. Infantile systemic hyalinosis presenting as pseudo-paralysis in infancy: Study of six cases. J Pediatr Genet. 2023;12(3):199-205. https://doi.org/10.1055/s-0041-1736558
  11. Oswal RM, Prasad SS, Manohar N, Pise GA, Rao K. Overlapping hyaline fibromatosis syndrome: A rare case of juvenile hyaline fibromatosis and infantile systemic hyalinosis. Cureus. 2022;14(8):e27947. https://doi.org/10.7759/cureus.27947.
  12. Hilado MA, Duong CPB, Siccama M. Hyaline fibromatosis syndrome presenting as abuse. Child Abuse Rev. 2025;34(2):e70029. https://doi.org/10.1002/car.70029.
  13. Alanazi A, Almatrafi HM, Alenazi SF, Almatrafi RM. Hyaline fibromatosis syndrome: A case report and review of the literature. Saudi J Med Pharm Sci. 2025;11(4):268-271. https://doi.org/10.1016/j.oooo.2020.06.022.
  14. Chaisrisawadisuk S, Rattana-Arpa S, Vathanophas V, Sathienkijkanchai A. Hyaline fibromatosis syndrome: Early outcomes following major craniofacial mass excision. J Craniofac Surg. 2024;35(5): e492-e495. https://doi.org/10.1097/SCS.0000000000010401.
  15. Schiavinato A, Pasanen-Zentz A, Mörgelin M, Wehrle A, Karmacharya S, Rübsam M, et al. ANTXR2 deficiency promotes cellular senescence and chondroid differentiation in hyaline fibromatosis syndrome fibroblasts. J Invest Dermatol. 2025;145(11):2911-2916.e7. https://doi.org/10.1016/j.jid.2025.04.022.
  16. Wang X, Wei J, Wang X. Recurrent giant subcutaneous tumor in juvenile hyaline fibromatosis. J Craniofac Surg. 2025;10-1097. https://doi.org/10.1097/SCS.0000000000011062.
  17. Chiaryath S, Bout-Tabaku S, Youssef T, Amin R, Ibrahim M, Bureshad K, Hussain K. Management of osteoporosis in a pediatric case of severe osteolysis. Endocrine Abstracts. 2025;110. https://doi.org/10.1530/endoabs.110.P288.
  18. Miyauchi K, Usui J, Shimizu T, Hattori A, Nomura S, Higashi T, et al. A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARS-CoV-2 vaccination. CEN Case Rep. 2025;1-7. https://doi.org/10.1007/s13730-025-00999-y.
  19. Lerner G. (2025). Investigation of Diabetic Kidney Disease in the Network for Pancreatic Organ Donors with Diabetes-Kidney Cohort. Kidney360, 6(1), 1–3. https://doi.org/10.34067/KID.0000000664.
  20. El-Khoury S, Chaaban M, Rizk S. Infantile systemic hyalinosis with novel ANTXR2 mutation: Expanding the genotype-phenotype spectrum. Case Rep Genet. 2024;2024:1-5. https://doi.org/10.1155/2024/5689123.
  21. Patel P, Banerjee R, Kadam R, et al. Infantile systemic hyalinosis with severe joint contractures: A diagnostic challenge. Indian J Pathol Microbiol. 2023;66(4):763-766. https://doi.org/10.4103/IJPM.IJPM_222_23.
  22. Rauf S, Ahmed S, Khalid S. Hyaline fibromatosis syndrome with unusual visceral involvement: A case report. BMJ Case Rep. 2022;15(9):e249876. https://doi.org/10.1186/s12903-021-01840-5.
  23. Yang J, Li W, Zhang Q, et al. Identification of compound heterozygous ANTXR2 mutations in a Chinese infant with systemic hyalinosis. Front Pediatr. 2024;12:1305892. https://doi.org/10.1002/ajmg.a.35228.
  24. Rehman U, Hussain S, Khan T, et al. Infantile systemic hyalinosis presenting as multiple subcutaneous nodules. J Pak Med Assoc. 2023;73(2):312-314. https://doi.org/10.7759/cureus.46519
  25. Moulonguet-Doleris L, Martin L, de Prost Y, et al. Juvenile hyaline fibromatosis and infantile systemic hyalinosis: Clinical and molecular overlap. Br J Dermatol. 2022;186(3):436-444. https://doi.org/10.1097/01.dad.0000245636.39098.e5.
  26. Momen S, Fattahi Z, Najafi M, et al. A novel ANTXR2 mutation in a consanguineous Iranian family with infantile systemic hyalinosis. Eur J Med Genet. 2023;66(6):104726. https://doi.org/10.1111/ced.12616.
  27. Al-Dawood A, Al-Mubarak Z, Al-Hussaini M. Infantile systemic hyalinosis with gastrointestinal manifestations: A case report and review. Saudi J Gastroenterol. 2024;30(1):58-62. https://doi.org/10.1016/j.jaad.2007.06.008.
  28. Choi Y, Kim E, Park Y. Infantile systemic hyalinosis diagnosed by whole-exome sequencing: Case report and review of genetic variants. Ann Lab Med. 2024;44(5):480-484. https://doi.org/10.7759/cureus.46519.
  29. Huang P, Chen Y, Wu T. Infantile systemic hyalinosis mimicking rheumatoid arthritis: A diagnostic pitfall. Clin Rheumatol. 2023;42(9):2507-2511. https://doi.org/10.1007/s10067-023-06589-4.
  30. Saeed M, Alzahrani H, Nasser M. Hyaline fibromatosis syndrome: Case report of a Saudi infant with severe phenotype. Med Case Rep. 2024;18(3):45-49. https://doi.org/10.36348/sjmps.2025.v11i04.005.
  31. Ramaswamy P, Balachandran S, Krishnan S, et al. A rare case of hyaline fibromatosis syndrome with extensive bone involvement. J Clin Orthop Trauma. 2024;44:102186. https://doi.org/10.1016/j.clinimag.2020.10.015.
  32. Kaur J, Sandhu R, Mehta A, et al. Hyaline fibromatosis syndrome presenting with gingival hypertrophy and joint contractures. Oral Surg Oral Med Oral Pathol Oral Radiol. 2023;136(1):71-75. https://doi.org/10.1016/j.oooo.2023.02.012.
  33. Tanaka Y, Sato M, Itoh H, et al. Functional impact of ANTXR2 mutations causing hyaline fibromatosis syndrome: Impaired collagen interaction and lysosomal trafficking. Hum Mol Genet. 2025;34(8):1345-1356. https://doi.org/10.1093/hmg/ddae013.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.